Oculis Holding AG (OCS)
8.72
+0.16
(+1.87%)
USD |
NASDAQ |
Oct 06, 16:00
8.72
0.00 (0.00%)
After-Hours: 18:36
Oculis Price to Book Value : 1.980 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 1.943 |
| October 02, 2026 | 1.982 |
| October 01, 2026 | 1.989 |
| September 30, 2026 | 2.120 |
| September 29, 2026 | 2.073 |
| September 28, 2026 | 2.057 |
| September 25, 2026 | 2.105 |
| September 24, 2026 | 2.136 |
| September 23, 2026 | 2.268 |
| September 22, 2026 | 2.432 |
| September 21, 2026 | 2.302 |
| September 18, 2026 | 2.302 |
| September 17, 2026 | 2.266 |
| September 16, 2026 | 2.250 |
| September 15, 2026 | 2.286 |
| September 14, 2026 | 2.406 |
| September 11, 2026 | 2.397 |
| September 10, 2026 | 2.568 |
| September 09, 2026 | 2.604 |
| September 08, 2026 | 2.761 |
| September 04, 2026 | 2.763 |
| September 03, 2026 | 2.763 |
| September 02, 2026 | 2.729 |
| September 01, 2026 | 2.765 |
| August 31, 2026 | 2.781 |
| Date | Value |
|---|---|
| August 28, 2026 | 2.772 |
| August 27, 2026 | 2.822 |
| August 26, 2026 | 2.945 |
| August 25, 2026 | 2.942 |
| August 24, 2026 | 2.992 |
| August 21, 2026 | 2.971 |
| August 20, 2026 | 2.983 |
| August 19, 2026 | 3.081 |
| August 18, 2026 | 2.994 |
| August 17, 2026 | 2.983 |
| August 14, 2026 | 2.938 |
| August 13, 2026 | 2.910 |
| August 12, 2026 | 2.926 |
| August 11, 2026 | 2.895 |
| August 10, 2026 | 2.897 |
| August 07, 2026 | 2.879 |
| August 06, 2026 | 2.811 |
| August 05, 2026 | 2.740 |
| August 04, 2026 | 2.722 |
| August 03, 2026 | 2.699 |
| July 31, 2026 | 2.568 |
| July 30, 2026 | 2.545 |
| July 29, 2026 | 2.461 |
| July 28, 2026 | 2.510 |
| July 27, 2026 | 2.502 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novartis AG | 6.202 |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 1.430 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Price to Book Value Related Metrics
| Price | 8.72 |
| Earnings Yield | -20.17% |
| Market Cap | 538.30M |